Schedule 13G ownership disclosure

LAKEFRONT BIOTHERAPEUTICS NV

Ordinary shares, no par value · CUSIP: 36315X101

Event date: 2025-10-27

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TANG CAPITAL MANAGEMENT, LLC

    Shares: 5,559,674.00 · Class: 8.4%

  • KEVIN TANG

    Shares: 5,559,674.00 · Class: 8.4%

  • TANG CAPITAL PARTNERS, LP

    Shares: 3,313,189.00 · Class: 5.0%

  • TANG CAPITAL PARTNERS INTERNATIONAL, LP

    Shares: 2,246,485.00 · Class: 3.4%

  • TANG CAPITAL PARTNERS III, INC

    Shares: 0.00 · Class: 0.0%

  • TANG CAPITAL PARTNERS IV, INC

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-015518
Form type
SCHEDULE 13G
Filer
Lakefront Biotherapeutics NV
CIK
CIK 1421876
Filed
Oct 29, 2025
Reporting period
Oct 27, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub